Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: A cohort study

BMC Geriatrics

Volumn 14, Issue 1, 2014, Pages

  Thorell, Kristine ^a,b   Ranstad, Karin ^b   Midlöv, Patrik ^b   Borgquist, Lars ^c   Halling, Anders ^b,d  

^a Blekinge County Hospital   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Elderly; Fall risk increasing drugs; Hip fracture; Medication review; Multimorbidity level; Sweden

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT;

AGED; CLINICAL TRIAL; FALLING; FEMALE; FOLLOW UP; HIP FRACTURES; HUMAN; MALE; MORBIDITY; MULTICENTER STUDY; ODDS RATIO; PREVENTION AND CONTROL; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SWEDEN; TRENDS; VERY ELDERLY;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MORBIDITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN;

EID: 84923860742     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-14-131     Document Type: Article

References (45)

1. Kanis JA, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B: Long-Term Risk of Osteoporotic Fracture in Malmö. Osteoporos Int 2000, 11(8):669-674.
2. Zethraeus N, Stromberg L, Jönsson B, Svensson O, Ohlen G: The cost of a hip fracture. Estimates for 1,709 patients in Sweden. Acta Orthop Scand 1997, 68(1):13-17.
3. Agusti A, Pages E, Cuxart A, Ballarin E, Vidal X, Teixidor J, Tomas J, Villar MM, Laporte JR: Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study. Eur J Clin Pharmacol 2012, 68(11):1525-1531.
4. Evans JG: Drugs and falls in later life. Lancet 2003, 361(9356):448.
5. Formiga F, Navarro M, Duaso E, Chivite D, Ruiz D, Perez-Castejon JM, Lopez- Soto A, Pujol R: Factors associated with hip fracture-related falls among patients with a history of recurrent falling. Bone 2008, 43(5):941-944.
6. Roche JJ, Wenn RT, Sahota O, Moran CG: Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005, 331(7529):1374.
7. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stheman-Bereen C: Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000, 58:396-399.
8. Banks E, Reeves GK, Beral V, Balkwill A, Liu B, Roddam A: Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis. PLoS Med 2009, 6(11):e1000181.
9. Chen JS, Sambrook PN, Simpson JM, Cameron ID, Cumming RG, Seibel MJ, Lord SR, March LM: Risk factors for hip fracture among institutionalised older people. Age Ageing 2009, 38(4):429-434.
10. Marks R, Allegrante JP, Ronald MacKenzie C, Lane JM: Hip fractures among the elderly: causes, consequences and control. Ageing Res Rev 2003, 2(1):57-93.
11. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y: Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 2013, 24(2):689-695.
12. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH: The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med 2012, 172(22):1739-1744.
13. Bowie MW, Slattum PW: Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007, 5(3):263-303.
14. Mangoni AA, Jackson SHD: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004, 57(1):6-14.
15. Chen Y, Zhu LL, Zhou Q: Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients. Ther Clin Risk Manag 2014, 10:437-448.
16. Fastbom J, Schmidt I: Indikatorer för god läkemedelsterapi hos äldre. In The Swedish National Bord for Health and Welfare 2010. Swedish: [http://www.socialstyrelsen.se/publikationer2010/2010-6-29]
17. Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R: Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005, 60(5):622-626.
18. Hanlon JT, Boudreau RM, Roumani YF, Newman AB, Ruby CM, Wright RM, Hilmer SN, Shorr RI, Bauer DC, Simonsick EM, Studenski SA: Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2009, 64(4):492-498.
19. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC: Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002, 50(10):1629-1637.
20. Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA: Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003, 163(8):949-957.
21. Leipzig RM, Cumming RG, Tinetti ME: Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs J Am Geriatr Soc 1999, 47(1):30-39.
22. Takkouche B, Montes-Martinez A, Gill SS, Etminan M: Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007, 30(2):171-184.
23. Pierfitte C, Macouillard G, Thicoipe M, Chaslerie A, Pehourcq F, Aissou M, Martinez B, Lagnaoui R, Fourrier A, Begaud B, Dangoumau J, Moore N: Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001, 322(7288):704-708.
24. Pacher P, Ungvari Z: Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses 2001, 57(4):469-471.
25. Leipzig RM, Cumming RG, Tinetti ME: Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs J Am Geriatr Soc 1999, 47(1):40-50.
26. Solomon DH, Mogun H, Garneau K, Fischer MA: Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 2011, 26(7):1561-1567.
27. Wirehn AB, Ostgren CJ, Carstensen JM: Age and gender differences in the impact of diabetes on the prevalence of ischemic heart disease: a population-based register study. Diabetes Res Clin Pract 2008, 79(3):497-502.
28. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment 2014. [http://www.whocc.no/atc-ddd-publications/guidelines/]
29. Starfield B, Weiner J, Mumford L, Steinwachs D: Ambulatory care groups: a categorization of diagnoses for research and management. Health Serv Res 1991, 26(1):53-74.
30. Zielinski A, Kronogard M, Lenhoff H, Halling A: Validation of ACG Case-mix for equitable resource allocation in Swedish primary health care. BMC Public Health 2009, 9:347.
31. Weiner JP, Starfield BH, Steinwachs DM, Mumford LM: Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 1991, 29(5):452-472.
32. Orueta JF, Lopez-De-Munain J, Baez K, Aiarzaguena JM, Aranguren JI, Pedrero E: Application of the ambulatory care groups in the primary care of a European national health care system: does it work? Med Care 1999, 37(3):238-248.
33. Cumming RG, Le Couteur DG: Benzodiazepines and Risk of Hip Fractures in Older People. CNS Drugs 2003, 17(11):825-838.
34. Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995, 155(16):1801-1807.
35. Weiner DK, Hanlon JT, Studenski A: Effects of Central Nervous System Polypharmacy on Falls Liability in Community-Dwelling Elderly. Gerontology 1998, 44(4):217-221.
36. Lee JS, Kwok T, Leung PC, Woo J: Medical illnesses are more important than medications as risk factors of falls in older community dwellers? A cross-sectional study. Age Ageing 2006, 35(3):246-251.
37. Milos V, Bondesson A, Magnusson M, Jakobsson U, Westerlund T, Midlov P: Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr 2014, 14:40.
38. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM: Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999, 47(7):850-853.
39. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH: Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006, 61(2):218-223.
40. Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S: Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 2003, 33(7):1223-1237.
41. Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ: Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry 2014, 204(2):98-107.
42. Statistics Sweden. [http://www.scb.se/sv-/Hitta-statistik/]
43. Carlsson L, Strender LE, Fridh G, Nilsson GH: Clinical categories of patients and encounter rates in primary health care - a three-year study in defined populations. BMC Public Health 2006, 6:35.
44. Hjerpe P, Merlo J, Ohlsson H, Bengtsson Bostrom K, Lindblad U: Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. BMC Med Inform Decis Mak 2010, 10:23.
45. Medical Products Agency: Medical Products Agencys work to counteracting illegal drugs. Uppsala: 2011.